Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial

Journal of Clinical Oncology

Volumn 29, Issue 9, 2011, Pages 1110-1116

  Ganz, Patricia A ^a   Land, Stephanie R ^a   Geyer Jr , Charles E ^a   Cecchini, Reena S ^a   Costantino, Joseph P ^a   Pajon, Eduardo R ^a   Fehrenbacher, Louis ^a   Atkins, James N ^a   Polikoff, Jonathan A ^a   Vogel, Victor G ^a   Erban, John K ^a   Livingston, Robert B ^a   Perez, Edith A ^a   Mamounas, Eleftherios P ^a   Wolmark, Norman ^a   Swain, Sandra M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; TAMOXIFEN;

ADULT; AMENORRHEA; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUATION; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; AMENORRHEA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MENSTRUATION; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SURVIVAL RATE; TAMOXIFEN; TAXOIDS; TREATMENT OUTCOME;

EID: 79952769473     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.29.7689     Document Type: Article

References (24)

1. Swain SM, Jeong JH, Geyer CE Jr, et al: Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med 362:2053-2065, 2010
2. Jeruss JS, Woodruff TK: Preservation of fertility in patients with cancer. N Engl J Med 360:902-911, 2009
3. Bines J, Oleske DM, Cobleigh MA: Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14:1718-1729, 1996 (Pubitemid 26134232)
4. Ganz PA, Rowland JH, Desmond K, et al: Life after breast cancer: Understanding women's health-related quality of life and sexual functioning. J Clin Oncol 16:501-514, 1998 (Pubitemid 28135592)
5. Ganz PA: Menopause and breast cancer: Symptoms, late effects, and their management. Semin Oncol 28:274-283, 2001
6. Ganz PA, Greendale GA, Petersen L, et al: Breast cancer in younger women: Reproductive and late health effects of treatment. J Clin Oncol 21: 4184-4193, 2003 (Pubitemid 46606187)
7. Walshe JM, Denduluri N, Swain SM: Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 24:5769-5779, 2006 (Pubitemid 46646480)
8. Petrek JA, Naughton MJ, Case LD, et al: Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: A prospective study. J Clin Oncol 24:1045-1051, 2006 (Pubitemid 46638800)
9. Swain S, Land S, Ritter M, et al: Amenorrhea in premenopausal women on the doxorubicin-andcyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial. Breast Cancer Res Treat 113:315-320, 2009
10. Land SR, Kopec JA, Yothers G, et al: Healthrelated quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: Findings from the National Surgical Adjuvant Breast and Bowel Project B-23. Breast Cancer Res Treat 86:153-164, 2004 (Pubitemid 38988018)
11. Land SR, Wickerham DL, Costantino JP, et al: Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 295:2742-2751, 2006
12. Brady MJ, Cella DF, Mo F, et al: Reliability and validity of the Functional Assessment of Cancer Therapy- Breast quality-of-life instrument. J Clin Oncol 15:974-986, 1997 (Pubitemid 27106280)
13. Cella DF, Tulsky DS, Gray G, et al: The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J Clin Oncol 11:570-579, 1993 (Pubitemid 23071057)
14. Eton DT, Cella D, Yost KJ, et al: A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol 57:898-910, 2004 (Pubitemid 39422527)
15. Ganz PA, Day R, Ware JE Jr, et al: Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention trial. J Natl Cancer Inst 87:1372-1382, 1995
16. Cella D, Land S, Chang CH, et al: Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): Psychometric properties of a new measure of symptoms for midlife women. Breast Cancer Res Treat 109:515-526, 2008 (Pubitemid 351692068)
17. Stanton AL, Bernaards CA, Ganz PA: The BCPT Symptom Scales: A measure of physical symptoms for women diagnosed with or at risk for breast cancer. J Natl Cancer Inst 97:448-456, 2005 (Pubitemid 40528608)
18. Land SR, Ritter MW, Costantino JP, et al: Compliance with patient-reported outcomes in multicenter clinical trials: Methodologic and practical approaches. J Clin Oncol 25:5113-5120, 2007 (Pubitemid 350232292)
19. Fisher B, Carbone P, Economou SG, et al: 1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer: A report of early findings. N Engl J Med 292:117-122, 1975
20. Fisher B, Fisher ER, Redmond C: Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. J Clin Oncol 4:929-941, 1986 (Pubitemid 16080947)
21. Goodwin PJ, Ennis M, Pritchard KI, et al: Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 17:2365-2370, 1999 (Pubitemid 29368234)
22. International Breast Cancer Study Group (IBCSG), Castiglione-Gersch M, O'Neill A, et al: Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: A randomized trial. J Natl Cancer Inst 95:1833-1846, 2003
23. Martin M, Pienkowski T, Mackey J, et al: Adjuvant docetaxel for node-positive breast cancer. N Engl J Med 352:2302-2313, 2005 (Pubitemid 40740554)
24. Lee SJ, Schover LR, Partridge AH, et al: American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917-2931, 2006 (Pubitemid 46655598)